Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Biographical Sketch
William D. Carey, M.D. M.A.C.G., is Director of the Hepatology (Liver) Center in the Department of Gastroenterology at Cleveland Clinic in Cleveland, Ohio. Dr. Carey is board-certified in internal medicine and gastroenterology, and specializes in liver disease, including medical management of liver transplantation and endoscopy.
After graduating from Tufts University School of Medicine in Boston, Dr. Carey completed his residency in internal medicine and a fellowship in nephrology at Presbyterian Hospital in San Francisco. He also completed a fellowship in gastroenterology at the Mayo Clinic in Rochester, Minn.
He is Past-President of the American College of Gastroenterology, and is active in many other professional groups, including the American Association for the Study of Liver Diseases, the American Gastroenterological Association, the American College of Physicians, the American Society for Gastrointestinal Endoscopy and the American Society for Transplant Physicians.
Specialty Interests
biliary disorders, biliary tract disease, drug induced liver disease, end stage liver disease, Endoscopy, Eval and management of Hepatobiliary Malignancies, general hepatology, hepatitis B, hepatitis C and liver disease, hepatology, liver, liver and biliary tract disease, Liver Disease, Liver Transplantation, liver-biliary tract disease, non alcoholic fatty liver disease, viral hepatitis
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the
pharmaceutical or medical device industries to help develop medical
breakthroughs or provide medical expertise or education. Cleveland Clinic
strives to make scientific advances that will benefit patient care and
support outside relationships that promise public benefit. In order for
the discoveries of Cleveland Clinic physicians' and scientists'
laboratories and investigations to benefit the public, these discoveries
must be commercialized in partnership with industry. As experts in their
fields, Cleveland Clinic physicians and scientists are often sought after
by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters,
Cleveland Clinic maintains a program that reviews these collaborations
and, when appropriate, puts measures in place to minimize bias that may
result from ties to industry. The Cleveland Clinic publicly discloses
the names of companies when (i) its physicians/scientists receive $5,000
or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its
physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its
physicians/scientists hold any equity interest for the
physician's/scientist's role as inventor, discoverer, developer, founder
or consultant.* In publicly disclosing this information, the Cleveland
Clinic tries to provide information as accurately as possible about its
physicians' and scientists' connections with industry.
As of 6/12/2010, Dr. Carey has reported no financial relationship
with industry that is applicable to this listing. In general, patients
should feel free to contact their doctor about any of the relationships
and how the relationships are overseen by the Cleveland Clinic. To learn
more about the Cleveland Clinic's policies on collaborations with industry
and innovation management, go to our
Integrity in Innovation
page.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
